IDH1 and central nervous system cancer: In addition, our cohort contained a larger sample size, thus, we assessed the diagnosis value IDH1-R132H and (or) ATRX status for human gliomas and observed that the progressive pattern of gliomas based on the precious cohort [2, 11, 30–32].